Opthea Limited Logo

Opthea Limited

OPT

(1.2)
Stock Price

3,33 USD

-198.78% ROA

613.5% ROE

-5.87x PER

Market Cap.

235.609.960,00 USD

-3.16% DER

0% Yield

-138174.47% NPM

Opthea Limited Stock Analysis

Opthea Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Opthea Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-14.5x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (-3%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

Negative ROE (-675.16%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-144.48%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Opthea Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Opthea Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Opthea Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Opthea Limited Revenue
Year Revenue Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 240.511 100%
1998 192.735 -24.79%
1999 2.938.822.649 99.99%
2000 0 0%
2001 0 0%
2002 9.571 100%
2003 0 0%
2004 12.235 100%
2005 13.344 8.3%
2006 0 0%
2007 19.130 100%
2008 14.351 -33.29%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 68.613 100%
2022 90.683 24.34%
2023 565.148 83.95%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Opthea Limited Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 7.669 100%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 600.340 100%
1999 358.334 -67.54%
2000 186.154 -92.49%
2001 553.000 66.34%
2002 144.691 -282.2%
2003 106.501 -35.86%
2004 349.779 69.55%
2005 533.751 34.47%
2006 1.201.367 55.57%
2007 2.674.405 55.08%
2008 3.271.367 18.25%
2009 3.618.360 9.59%
2010 3.650.477 0.88%
2011 7.021.883 48.01%
2012 3.679.797 -90.82%
2013 3.136.297 -17.33%
2014 3.401.685 7.8%
2015 4.284.229 20.6%
2016 2.674.444 -60.19%
2017 3.717.994 28.07%
2018 18.285.120 79.67%
2019 21.954.150 16.71%
2020 12.336.602 -77.96%
2021 25.891.851 52.35%
2022 78.654.217 67.08%
2023 182.254.188 56.84%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Opthea Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 0 0%
1991 59.818 100%
1992 43.326 -38.07%
1993 74.816 42.09%
1994 113.259 33.94%
1995 132.098 14.26%
1996 204.750 35.48%
1997 252.308 18.85%
1998 0 0%
1999 332.209 100%
2000 320.839 -3.54%
2001 1.880.000 82.93%
2002 1.161.468 -61.86%
2003 1.322.733 12.19%
2004 1.341.585 1.41%
2005 1.648.592 18.62%
2006 2.039.456 19.17%
2007 3.394.989 39.93%
2008 3.438.889 1.28%
2009 3.766.971 8.71%
2010 4.567.863 17.53%
2011 4.364.806 -4.65%
2012 3.584.465 -21.77%
2013 3.109.225 -15.28%
2014 2.652.041 -17.24%
2015 2.361.587 -12.3%
2016 2.863.441 17.53%
2017 3.250.164 11.9%
2018 2.699.847 -20.38%
2019 3.073.279 12.15%
2020 4.001.391 23.19%
2021 13.720.226 70.84%
2022 17.831.485 23.06%
2023 39.455.312 54.81%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Opthea Limited EBITDA
Year EBITDA Growth
1989 -511.891
1990 -627.419 18.41%
1991 -163.350 -284.1%
1992 -72.459 -125.44%
1993 -348.027 79.18%
1994 -78.916 -341.02%
1995 -521.999 84.88%
1996 -967.051 46.02%
1997 240.511 502.08%
1998 192.735 -24.79%
1999 2.938.822.649 99.99%
2000 -534.339 550093.2%
2001 -807.295 33.81%
2002 -3.216.417 74.9%
2003 -2.941.634 -9.34%
2004 -1.783.908 -64.9%
2005 17.634.379 110.12%
2006 -3.907.416 551.31%
2007 -37.876.643 89.68%
2008 -12.626.437 -199.98%
2009 -7.574.400 -66.7%
2010 -10.171.625 25.53%
2011 -11.196.543 9.15%
2012 -8.918.896 -25.54%
2013 -7.223.530 -23.47%
2014 -6.256.098 -15.46%
2015 -6.973.374 10.29%
2016 -5.179.097 -34.64%
2017 -7.497.033 30.92%
2018 -21.730.123 65.5%
2019 -25.965.704 16.31%
2020 -17.107.424 -51.78%
2021 -28.521.885 40.02%
2022 -93.645.419 69.54%
2023 -213.821.416 56.2%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Opthea Limited Gross Profit
Year Gross Profit Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 240.511 100%
1998 192.735 -24.79%
1999 2.938.822.649 99.99%
2000 -27.346 10746909.95%
2001 0 0%
2002 9.571 100%
2003 0 0%
2004 12.235 100%
2005 13.344 8.3%
2006 0 0%
2007 19.130 100%
2008 14.351 -33.29%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 68.613 100%
2022 90.683 24.34%
2023 309.297 70.68%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Opthea Limited Net Profit
Year Net Profit Growth
1989 -410.721
1990 -492.576 16.62%
1991 -138.809 -254.86%
1992 -60.507 -129.41%
1993 -341.347 82.27%
1994 -45.303 -653.48%
1995 -472.284 90.41%
1996 -857.588 44.93%
1997 -1.053.626 18.61%
1998 -1.229.823 14.33%
1999 1.582.301.886 100.08%
2000 730.417 -216529.94%
2001 -801.172 191.17%
2002 -3.233.870 75.23%
2003 -2.362.860 -36.86%
2004 4.056.890 158.24%
2005 16.599.334 75.56%
2006 -4.802.887 445.61%
2007 9.502.444 150.54%
2008 -1.098.157 965.31%
2009 -8.003.235 86.28%
2010 -5.905.103 -35.53%
2011 -10.971.235 46.18%
2012 -4.950.420 -121.62%
2013 -4.339.225 -14.09%
2014 -3.762.350 -15.33%
2015 -4.074.368 7.66%
2016 -4.859.620 16.16%
2017 -4.758.934 -2.12%
2018 -12.416.249 61.67%
2019 -14.644.130 15.21%
2020 -11.357.599 -28.94%
2021 -45.344.496 74.95%
2022 -92.817.371 51.15%
2023 -196.449.396 52.75%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Opthea Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 -1 0%
2003 0 0%
2004 1 0%
2005 3 100%
2006 -1 0%
2007 2 100%
2008 0 0%
2009 -1 100%
2010 -1 0%
2011 -2 0%
2012 -1 0%
2013 -1 0%
2014 -1 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 -1 0%
2020 0 0%
2021 -1 100%
2022 -2 50%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Opthea Limited Free Cashflow
Year Free Cashflow Growth
1989 0
1990 0 0%
1991 -197.000 100%
1992 -267.000 26.22%
1993 -351.000 23.93%
1994 -477.038 26.42%
1995 -676.261 29.46%
1996 -1.222.875 44.7%
1997 -1.785.912 31.53%
1998 -72.154 -2375.14%
1999 -12.460.000 99.42%
2000 -14.650 -84957%
2001 -1.031.150 98.58%
2002 -1.053.330 2.11%
2003 -15.113 -6870.15%
2004 -1.713.046 99.12%
2005 -1.643.260 -4.25%
2006 -2.900.347 43.34%
2007 32.915.507 108.81%
2008 -1.828.958 1899.69%
2009 -6.601.107 72.29%
2010 -7.562.583 12.71%
2011 -9.497.729 20.37%
2012 -7.213.302 -31.67%
2013 -5.615.724 -28.45%
2014 -4.285.430 -31.04%
2015 -5.026.656 14.75%
2016 -3.689.992 -36.22%
2017 -6.047.803 38.99%
2018 -19.962.832 69.7%
2019 -16.950.462 -17.77%
2020 -6.039.445 -180.66%
2021 -45.558.869 86.74%
2022 -71.351.862 36.15%
2023 -38.538.651 -85.14%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Opthea Limited Operating Cashflow
Year Operating Cashflow Growth
1989 0
1990 0 0%
1991 -197.000 100%
1992 -267.000 26.22%
1993 -351.000 23.93%
1994 -469.000 25.16%
1995 -672.000 30.21%
1996 -1.215.000 44.69%
1997 -1.740.962 30.21%
1998 0 0%
1999 0 0%
2000 0 0%
2001 -1.005.125 100%
2002 -1.040.944 3.44%
2003 0 0%
2004 -1.708.946 100%
2005 -1.636.369 -4.44%
2006 -2.888.112 43.34%
2007 32.971.572 108.76%
2008 -1.798.092 1933.7%
2009 -6.589.155 72.71%
2010 -7.542.908 12.64%
2011 -9.415.565 19.89%
2012 -7.173.904 -31.25%
2013 -5.612.996 -27.81%
2014 -4.174.307 -34.47%
2015 -5.026.656 16.96%
2016 -3.681.236 -36.55%
2017 -6.045.438 39.11%
2018 -19.937.550 69.68%
2019 -16.937.807 -17.71%
2020 -6.034.471 -180.68%
2021 -45.546.167 86.75%
2022 -71.334.952 36.15%
2023 -38.527.440 -85.15%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Opthea Limited Capital Expenditure
Year Capital Expenditure Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 8.038 100%
1995 4.261 -88.62%
1996 7.875 45.89%
1997 44.950 82.48%
1998 72.154 37.7%
1999 12.460.000 99.42%
2000 14.650 -84957%
2001 26.025 43.71%
2002 12.386 -110.13%
2003 15.113 18.05%
2004 4.100 -268.68%
2005 6.891 40.51%
2006 12.235 43.68%
2007 56.065 78.18%
2008 30.866 -81.65%
2009 11.952 -158.26%
2010 19.675 39.26%
2011 82.164 76.05%
2012 39.398 -108.55%
2013 2.728 -1344.7%
2014 111.123 97.55%
2015 0 0%
2016 8.756 100%
2017 2.365 -270.39%
2018 25.282 90.65%
2019 12.655 -99.78%
2020 4.973 -154.47%
2021 12.702 60.85%
2022 16.910 24.88%
2023 11.211 -50.85%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Opthea Limited Equity
Year Equity Growth
1989 2.446.206
1990 1.505.489 -62.49%
1991 1.316.768 -14.33%
1992 1.647.880 20.09%
1993 1.626.576 -1.31%
1994 2.099.302 22.52%
1995 2.074.500 -1.2%
1996 3.829.616 45.83%
1997 5.323.536 28.06%
1998 4.329.192 -22.97%
1999 7.155.912 39.5%
2000 14.999.212 52.29%
2001 23.972.383 37.43%
2002 23.278.910 -2.98%
2003 24.514.307 5.04%
2004 29.151.403 15.91%
2005 28.519.777 -2.21%
2006 41.993.364 32.09%
2007 47.366.794 11.34%
2008 45.374.107 -4.39%
2009 31.272.393 -45.09%
2010 27.042.956 -15.64%
2011 23.324.897 -15.94%
2012 19.353.821 -20.52%
2013 12.275.946 -57.66%
2014 8.977.318 -36.74%
2015 16.033.388 44.01%
2016 11.185.406 -43.34%
2017 41.874.377 73.29%
2018 28.041.171 -49.33%
2019 21.794.224 -28.66%
2020 44.530.963 51.06%
2021 135.285.768 67.08%
2022 47.977.144 -181.98%
2023 -5.758.549 933.15%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Opthea Limited Assets
Year Assets Growth
1989 2.445.451
1990 1.530.871 -59.74%
1991 1.322.137 -15.79%
1992 1.668.796 20.77%
1993 1.637.264 -1.93%
1994 2.125.607 22.97%
1995 2.142.680 0.8%
1996 3.929.629 45.47%
1997 5.490.803 28.43%
1998 4.491.130 -22.26%
1999 7.298.018 38.46%
2000 15.217.297 52.04%
2001 24.366.334 37.55%
2002 23.487.783 -3.74%
2003 24.832.563 5.42%
2004 29.463.741 15.72%
2005 32.917.453 10.49%
2006 43.787.021 24.82%
2007 56.707.956 22.79%
2008 51.523.232 -10.06%
2009 33.314.363 -54.66%
2010 29.463.662 -13.07%
2011 26.187.287 -12.51%
2012 23.133.833 -13.2%
2013 14.977.558 -54.46%
2014 11.732.289 -27.66%
2015 18.463.893 36.46%
2016 12.734.564 -44.99%
2017 43.451.777 70.69%
2018 33.846.951 -28.38%
2019 26.375.089 -28.33%
2020 49.395.127 46.6%
2021 138.409.168 64.31%
2022 60.046.819 -130.5%
2023 98.641.320 39.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Opthea Limited Liabilities
Year Liabilities Growth
1989 34.730
1990 25.382 -36.83%
1991 29.142 12.9%
1992 38.844 24.97%
1993 21.376 -81.72%
1994 32.151 33.51%
1995 68.890 53.33%
1996 95.288 27.7%
1997 167.267 43.03%
1998 161.938 -3.29%
1999 142.106 -13.96%
2000 218.085 34.84%
2001 165.848 -31.5%
2002 208.873 20.6%
2003 318.255 34.37%
2004 312.338 -1.89%
2005 4.289.086 92.72%
2006 1.719.839 -149.39%
2007 4.998.281 65.59%
2008 2.339.419 -113.65%
2009 2.022.421 -15.67%
2010 2.420.706 16.45%
2011 2.862.390 15.43%
2012 2.464.477 -16.15%
2013 1.873.580 -31.54%
2014 1.866.117 -0.4%
2015 1.803.405 -3.48%
2016 1.549.158 -16.41%
2017 1.577.401 1.79%
2018 5.805.780 72.83%
2019 4.580.865 -26.74%
2020 4.864.164 5.82%
2021 3.123.400 -55.73%
2022 12.069.675 74.12%
2023 104.399.869 88.44%

Opthea Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.47
Price to Earning Ratio
-5.87x
Price To Sales Ratio
417.68x
POCF Ratio
-6.92
PFCF Ratio
-1.42
Price to Book Ratio
-199.73
EV to Sales
259.89
EV Over EBITDA
-0.69
EV to Operating CashFlow
-0.88
EV to FreeCashFlow
-0.88
Earnings Yield
-0.17
FreeCashFlow Yield
-0.71
Market Cap
0,24 Bil.
Enterprise Value
0,15 Bil.
Graham Number
0.38
Graham NetNet
-0.02

Income Statement Metrics

Net Income per Share
-0.47
Income Quality
0.82
ROE
-23.63
Return On Assets
-0.97
Return On Capital Employed
-1.24
Net Income per EBT
0.95
EBT Per Ebit
1.03
Ebit per Revenue
-1412.09
Effective Tax Rate
0.05

Margins

Sales, General, & Administrative to Revenue
69.81
Research & Developement to Revenue
322.49
Stock Based Compensation to Revenue
15.59
Gross Profit Margin
-0.53
Operating Profit Margin
-1412.09
Pretax Profit Margin
-1457.97
Net Profit Margin
-1381.74

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.4
Free CashFlow per Share
-0.4
Capex to Operating CashFlow
0
Capex to Revenue
-0.07
Capex to Depreciation
-0.24
Return on Invested Capital
41.78
Return on Tangible Assets
-1.99
Days Sales Outstanding
4246.57
Days Payables Outstanding
25437.21
Days of Inventory on Hand
0
Receivables Turnover
0.09
Payables Turnover
0.01
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,21
Book Value per Share
-0,01
Tangible Book Value per Share
-0.01
Shareholders Equity per Share
-0.01
Interest Debt per Share
0
Debt to Equity
-0.03
Debt to Assets
0
Net Debt to EBITDA
0.42
Current Ratio
5.28
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-0.03
Working Capital
0,08 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Opthea Limited Dividends
Year Dividends Growth

Opthea Limited Profile

About Opthea Limited

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

CEO
Dr. Frederic Guerard M.S., Ph
Employee
24
Address
650 Chapel Street
South Yarra, 3141

Opthea Limited Executives & BODs

Opthea Limited Executives & BODs
# Name Age
1 Dr. Fang Li Ph.D.
Senior Vice President of Regulatory Affairs
70
2 Ms. Sarika Gulhar Ph.D.
Executive Director of Human Resources
70
3 Dr. Kenneth Sall
Chief Medical Officer
70
4 Dr. Frederic Guerard M.S., Pharm.D.
Chief Executive Officer
70
5 Ms. Karen Adams CPA
Vice President of Finance & Company Secretary
70
6 Dr. Michael Gerometta Ph.D.
Head of Chemistry, Manufacturing & Controls Development
70
7 Mr. Bruno Gagnon BPHARM, M.Sc.
Senior Vice President of Global Clinical Operations
70
8 Mr. Peter F. Lang M.B.A.
Chief Financial Officer
70
9 Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D.
Founder, Chief Innovation Officer & Executive Director
70
10 Ms. Judith J. Robertson B.A., M.B.A.
Chief Commercial Officer
70

Opthea Limited Competitors